The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Hypertensive Drugs Market Research Report 2025
Synopsis
The global Anti-Hypertensive Drugs market was valued at US$ 39740 million in 2023 and is anticipated to reach US$ 46250 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Hypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Hypertensive Drugs.
Report Scope
The Anti-Hypertensive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Hypertensive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Hypertensive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical
Segment by Type
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Hypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Hypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Anti-Hypertensive Drugs market was valued at US$ 39740 million in 2023 and is anticipated to reach US$ 46250 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Hypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Hypertensive Drugs.
Report Scope
The Anti-Hypertensive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Hypertensive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Hypertensive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical
Segment by Type
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Hypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Hypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Hypertensive Drugs Market Overview
1.1 Product Overview and Scope of Anti-Hypertensive Drugs
1.2 Anti-Hypertensive Drugs Segment by Type
1.2.1 Global Anti-Hypertensive Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Diuretics
1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.4 Angiotensin Receptor Blockers (ARBs)
1.2.5 Calcium Channel Blockers
1.2.6 Beta Blockers
1.2.7 Alpha Blockers
1.2.8 Vasodilators
1.2.9 Renin Inhibitors
1.3 Anti-Hypertensive Drugs Segment by Application
1.3.1 Global Anti-Hypertensive Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Anti-Hypertensive Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Hypertensive Drugs Revenue 2019-2030
1.4.2 Global Anti-Hypertensive Drugs Sales 2019-2030
1.4.3 Global Anti-Hypertensive Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Hypertensive Drugs Market Competition by Manufacturers
2.1 Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Hypertensive Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Hypertensive Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Hypertensive Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Hypertensive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Hypertensive Drugs, Product Type & Application
2.7 Anti-Hypertensive Drugs Market Competitive Situation and Trends
2.7.1 Anti-Hypertensive Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Hypertensive Drugs Players Market Share by Revenue
2.7.3 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Hypertensive Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Hypertensive Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Hypertensive Drugs Global Anti-Hypertensive Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-Hypertensive Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-Hypertensive Drugs Sales by Region: 2025-2030
3.3 Global Anti-Hypertensive Drugs Global Anti-Hypertensive Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-Hypertensive Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-Hypertensive Drugs Revenue by Region: 2025-2030
3.4 North America Anti-Hypertensive Drugs Market Facts & Figures by Country
3.4.1 North America Anti-Hypertensive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Hypertensive Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-Hypertensive Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Hypertensive Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-Hypertensive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Hypertensive Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-Hypertensive Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Hypertensive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Hypertensive Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Hypertensive Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Hypertensive Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-Hypertensive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Hypertensive Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-Hypertensive Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Hypertensive Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Hypertensive Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Hypertensive Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-Hypertensive Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-Hypertensive Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-Hypertensive Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-Hypertensive Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-Hypertensive Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-Hypertensive Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-Hypertensive Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Hypertensive Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Hypertensive Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-Hypertensive Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-Hypertensive Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-Hypertensive Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-Hypertensive Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-Hypertensive Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-Hypertensive Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-Hypertensive Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Hypertensive Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Anti-Hypertensive Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Anti-Hypertensive Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Anti-Hypertensive Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Anti-Hypertensive Drugs Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Corporation Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lupin Anti-Hypertensive Drugs Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Ranbaxy Laboratories
6.6.1 Ranbaxy Laboratories Corporation Information
6.6.2 Ranbaxy Laboratories Description and Business Overview
6.6.3 Ranbaxy Laboratories Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Product Portfolio
6.6.5 Ranbaxy Laboratories Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Anti-Hypertensive Drugs Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Anti-Hypertensive Drugs Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Daiichi Sankyo Company Limited
6.9.1 Daiichi Sankyo Company Limited Corporation Information
6.9.2 Daiichi Sankyo Company Limited Description and Business Overview
6.9.3 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product Portfolio
6.9.5 Daiichi Sankyo Company Limited Recent Developments/Updates
6.10 Takeda Pharmaceutical
6.10.1 Takeda Pharmaceutical Corporation Information
6.10.2 Takeda Pharmaceutical Description and Business Overview
6.10.3 Takeda Pharmaceutical Anti-Hypertensive Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Product Portfolio
6.10.5 Takeda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Hypertensive Drugs Industry Chain Analysis
7.2 Anti-Hypertensive Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Hypertensive Drugs Production Mode & Process
7.4 Anti-Hypertensive Drugs Sales and Marketing
7.4.1 Anti-Hypertensive Drugs Sales Channels
7.4.2 Anti-Hypertensive Drugs Distributors
7.5 Anti-Hypertensive Drugs Customers
8 Anti-Hypertensive Drugs Market Dynamics
8.1 Anti-Hypertensive Drugs Industry Trends
8.2 Anti-Hypertensive Drugs Market Drivers
8.3 Anti-Hypertensive Drugs Market Challenges
8.4 Anti-Hypertensive Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-Hypertensive Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Hypertensive Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Hypertensive Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Hypertensive Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Hypertensive Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Hypertensive Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Hypertensive Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Hypertensive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Hypertensive Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Hypertensive Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Hypertensive Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Hypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Hypertensive Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Hypertensive Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Hypertensive Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Hypertensive Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Hypertensive Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Hypertensive Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Hypertensive Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Hypertensive Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Hypertensive Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Hypertensive Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Hypertensive Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Hypertensive Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Hypertensive Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Hypertensive Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Hypertensive Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Hypertensive Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Hypertensive Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Hypertensive Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Hypertensive Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Hypertensive Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Hypertensive Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Hypertensive Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Hypertensive Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Hypertensive Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Hypertensive Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Hypertensive Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Hypertensive Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Hypertensive Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Hypertensive Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Hypertensive Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Hypertensive Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Hypertensive Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Hypertensive Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Hypertensive Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Hypertensive Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Hypertensive Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Anti-Hypertensive Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Hypertensive Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Hypertensive Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Hypertensive Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Hypertensive Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Hypertensive Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Hypertensive Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Novartis Anti-Hypertensive Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Pfizer Anti-Hypertensive Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Anti-Hypertensive Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Sanofi Anti-Hypertensive Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Lupin Corporation Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Lupin Anti-Hypertensive Drugs Product
Table 94. Lupin Recent Developments/Updates
Table 95. Ranbaxy Laboratories Corporation Information
Table 96. Ranbaxy Laboratories Description and Business Overview
Table 97. Ranbaxy Laboratories Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Ranbaxy Laboratories Anti-Hypertensive Drugs Product
Table 99. Ranbaxy Laboratories Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Merck Anti-Hypertensive Drugs Product
Table 104. Merck Recent Developments/Updates
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. AstraZeneca Anti-Hypertensive Drugs Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Daiichi Sankyo Company Limited Corporation Information
Table 111. Daiichi Sankyo Company Limited Description and Business Overview
Table 112. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Product
Table 114. Daiichi Sankyo Company Limited Recent Developments/Updates
Table 115. Takeda Pharmaceutical Corporation Information
Table 116. Takeda Pharmaceutical Description and Business Overview
Table 117. Takeda Pharmaceutical Anti-Hypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Takeda Pharmaceutical Anti-Hypertensive Drugs Product
Table 119. Takeda Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Anti-Hypertensive Drugs Distributors List
Table 123. Anti-Hypertensive Drugs Customers List
Table 124. Anti-Hypertensive Drugs Market Trends
Table 125. Anti-Hypertensive Drugs Market Drivers
Table 126. Anti-Hypertensive Drugs Market Challenges
Table 127. Anti-Hypertensive Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Hypertensive Drugs
Figure 2. Global Anti-Hypertensive Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Hypertensive Drugs Market Share by Type in 2023 & 2030
Figure 4. Diuretics Product Picture
Figure 5. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
Figure 6. Angiotensin Receptor Blockers (ARBs) Product Picture
Figure 7. Calcium Channel Blockers Product Picture
Figure 8. Beta Blockers Product Picture
Figure 9. Alpha Blockers Product Picture
Figure 10. Vasodilators Product Picture
Figure 11. Renin Inhibitors Product Picture
Figure 12. Global Anti-Hypertensive Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 13. Global Anti-Hypertensive Drugs Market Share by Application in 2023 & 2030
Figure 14. Hospital Pharmacies
Figure 15. Retail Pharmacies
Figure 16. Online Pharmacies
Figure 17. Global Anti-Hypertensive Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Anti-Hypertensive Drugs Market Size (2019-2030) & (US$ Million)
Figure 19. Global Anti-Hypertensive Drugs Sales (2019-2030) & (K Units)
Figure 20. Global Anti-Hypertensive Drugs Average Price (USD/Pcs) & (2019-2030)
Figure 21. Anti-Hypertensive Drugs Report Years Considered
Figure 22. Anti-Hypertensive Drugs Sales Share by Manufacturers in 2023
Figure 23. Global Anti-Hypertensive Drugs Revenue Share by Manufacturers in 2023
Figure 24. The Global 5 and 10 Largest Anti-Hypertensive Drugs Players: Market Share by Revenue in 2023
Figure 25. Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 26. Global Anti-Hypertensive Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 27. North America Anti-Hypertensive Drugs Sales Market Share by Country (2019-2030)
Figure 28. North America Anti-Hypertensive Drugs Revenue Market Share by Country (2019-2030)
Figure 29. U.S. Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Canada Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Europe Anti-Hypertensive Drugs Sales Market Share by Country (2019-2030)
Figure 32. Europe Anti-Hypertensive Drugs Revenue Market Share by Country (2019-2030)
Figure 33. Germany Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. France Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. U.K. Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Italy Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Russia Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Asia Pacific Anti-Hypertensive Drugs Sales Market Share by Region (2019-2030)
Figure 39. Asia Pacific Anti-Hypertensive Drugs Revenue Market Share by Region (2019-2030)
Figure 40. China Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Japan Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. South Korea Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. India Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Australia Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Taiwan Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Indonesia Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Thailand Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Malaysia Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Philippines Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Anti-Hypertensive Drugs Sales Market Share by Country (2019-2030)
Figure 51. Latin America Anti-Hypertensive Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Mexico Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Argentina Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East & Africa Anti-Hypertensive Drugs Sales Market Share by Country (2019-2030)
Figure 56. Middle East & Africa Anti-Hypertensive Drugs Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. U.A.E Anti-Hypertensive Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Anti-Hypertensive Drugs by Type (2019-2030)
Figure 61. Global Revenue Market Share of Anti-Hypertensive Drugs by Type (2019-2030)
Figure 62. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Type (2019-2030)
Figure 63. Global Sales Market Share of Anti-Hypertensive Drugs by Application (2019-2030)
Figure 64. Global Revenue Market Share of Anti-Hypertensive Drugs by Application (2019-2030)
Figure 65. Global Anti-Hypertensive Drugs Price (USD/Pcs) by Application (2019-2030)
Figure 66. Anti-Hypertensive Drugs Value Chain
Figure 67. Anti-Hypertensive Drugs Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Distributors Profiles
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
